Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Assess which IRA (Roth or Traditional) provides better index fund options by evaluating fund availability, fees, and diversification.
25,782 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Rising tensions near the Strait of Hormuz are driving fertilizer costs higher, prompting farmers to reassess spring p...
In morning trading, Tesla sinks about 5% while Lucid edges higher and Rivian drifts, signaling a diverging path for t...
In this analysis, we unpack what Andy Jassy's recent remarks mean for Amazon stock and AWS growth. Learn actionable s...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Bitcoin has been in the news for years, but the big question remains: is it late to buy? This guide breaks down the r...
As MiCA’s July 1 deadline approaches, EU platforms must be MiCA-compliant, while the UK maintains its own FCA framewo...
When insider moves hit the headlines, investors seek clarity. This piece breaks down what it means when the holdings ...
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Airbnb (ABNB) enters 2026 with evolving monetization and travel demand. This guide breaks down Q1 insights, margins, ...
Nvidia just landed a significant AI deal that could shift its growth trajectory. This article breaks down what invest...
Telos (TLS) 2026 earnings outlook is shaping up as multiple revenue streams converge—from on-chain activity fees to s...